charles c hong
Michigan State University
East Lansing, United States
Specialty Chief Editor
Cardiovascular and Hematologic Drugs
Central Institute of Medicinal and Aromatic Plants, Council of Scientific and Industrial Research (CSIR)
Lucknow, India
Associate Editor
Cardiovascular and Hematologic Drugs
Perelman School of Medicine, University of Pennsylvania
Philadelphia, United States
Associate Editor
Cardiovascular and Hematologic Drugs
Tufts Medical Center
Boston, United States
Associate Editor
Cardiovascular and Hematologic Drugs
U.P. Pandit Deen Dayal Upadhyaya Veterinary University
Mathura, India
Associate Editor
Cardiovascular and Hematologic Drugs
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, United States
Associate Editor
Cardiovascular and Hematologic Drugs
CVPath Institute
Gaithersburg, United States
Associate Editor
Cardiovascular and Hematologic Drugs
Cydan Development, Inc.
Cambridge, United States
Associate Editor
Cardiovascular and Hematologic Drugs
Maze Therapeutics
San Francisco, United States
Associate Editor
Cardiovascular and Hematologic Drugs
Wexner Medical Center, The Ohio State University
Columbus, United States
Associate Editor
Cardiovascular and Hematologic Drugs
Department of Pharmacology and Toxicology, College of Pharmacy, The University of Utah
Salt Lake City, United States
Associate Editor
Cardiovascular and Hematologic Drugs
Johns Hopkins University
Baltimore, United States
Associate Editor
Cardiovascular and Hematologic Drugs
Spanish National Centre for Cardiovascular Research
Madrid, Spain
Associate Editor
Cardiovascular and Hematologic Drugs
Stanford University
Stanford, United States
Associate Editor
Cardiovascular and Hematologic Drugs
INSERM U1220 Institut de Recherche en Santé Digestive
Toulouse, France
Associate Editor
Cardiovascular and Hematologic Drugs
Leducq Foundation
Paris, France
Associate Editor
Cardiovascular and Hematologic Drugs